BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19
• 22
• 23
• 24
• 25
• 26
• 29
• 30
• 31

• Drug Development

  Zhiyi Biotech Successfully Completes Phase I Clinical Trial of SK10 for the Treatment of Chemotherapy-induced Diarrhea

  July 8, 2024

   · 

  2 min read
• Business

  Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - July 05, 2024

  July 8, 2024

   · 

  2 min read
• Business

  Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - July 05, 2024

  July 8, 2024

   · 

  2 min read
• Business

  Chimerix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - July 05, 2024

  July 8, 2024

   · 

  1 min read
• Business

  Fortress Biotech Announces Pause in Payment of Dividends on 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock

  July 8, 2024

   · 

  5 min read
• Business

  BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - July 05, 2024

  July 8, 2024

   · 

  1 min read
• Drug Development

  IDEAYA Announces Investor Webcast to Report Clinical Data Update for IDE397 Phase 2 Monotherapy Expansion Dose in MTAP-Deletion Urothelial and Lung Cancer on Monday, July 8, 2024

  July 8, 2024

   · 

  4 min read
• Business

  ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - July 05, 2024

  July 8, 2024

   · 

  5 min read
• Business

  Myricx Bio Announces £90m ($114m) Series A Financing to Advance its Novel NMTi-ADC Therapeutics into Clinical Development

  July 8, 2024

   · 

  10 min read
• Business

  Memo Therapeutics AG appoints Paul Carter as Chairperson

  July 8, 2024

   · 

  3 min read